The present invention relates to a compound according to Formula (I)
wherein
R
1
is selected from C
1
-C
6
alkyl, and said C
1
-C
6
alkyl is substituted with C
1
-C
6
alkoxy; and at least one of said C
1
-C
6
alkyl or said C
1
-C
6
alkoxy is branched; or a pharmaceutically acceptable salt thereof, solvate or solvate of a salt thereof, as well as, to compositions containing at least one compound according to Formula (I) and methods of treating at least one disease or condition therewith.
2-Thioxanthine Derivatives Acting as MPO-Inhibitors
申请人:Tiden Anna-Karin
公开号:US20090131459A1
公开(公告)日:2009-05-21
The present invention relates to a compound according to Formula (I) wherein R
1
is selected from C
1
-C
6
alkyl, and said C
1
-C
6
alkyl is substituted with C
1
-C
6
alkoxy; and at least one of said C
1
-C
6
alkyl or said C
1
-C
6
alkoxy is branched; or a pharmaceutically acceptable salt thereof, solvate or solvate of a salt thereof, to compositions containing the compound and the use thereof in therapy.
2-THIOXANTHINE DERIVATIVES ACTING AS MPO-INHIBITORS
申请人:Astra Zeneca AB
公开号:EP2029598A1
公开(公告)日:2009-03-04
US7943625B2
申请人:——
公开号:US7943625B2
公开(公告)日:2011-05-17
[EN] 2-THIOXANTHINE DERIVATIVES ACTING AS MPO-INHIBITORS<br/>[FR] DÉRIVÉS DE 2-THIOXANTHÈNE AGISSANT EN TANT QU'INHIBITEURS DE LA MYÉLOPEROXYDASE (MPO)
申请人:ASTRAZENECA AB
公开号:WO2007142576A1
公开(公告)日:2007-12-13
[EN] The present invention relates to a compound according to Formula (I) wherein R1 is selected from C1-C6 alkyl, and said C1-C6 alkyl is substituted with C1-C6 alkoxy; and at least one of said C1-C6 alkyl or said C1-C6 alkoxy is branched; or a pharmaceutically acceptable salt thereof, solvate or solvate of a salt thereof, to compositions containing the compound and the use thereof in therapy. [FR] La présente invention concerne un composé selon la formule (I), dans laquelle R1 est choisi parmi alkyle C1-C6, et ledit alkyle C1-C6 est substitué par alcoxy C1-C6; et au moins un élément parmi ledit alkyle C1-C6 ou ledit alcoxy C1-C6 est ramifié; ou un sel pharmaceutiquement acceptable de celui-ci, un solvate ou un solvate d'un sel de celui-ci, des compositions contenant le composé et l'utilisation de celles-ci dans la thérapie.